EyePoint Pharmaceuticals Inc. sell StockNews.com
Start price
04.03.23
/
50%
€3.04
Target price
04.03.24
-
Performance (%)
669.74%
End price
05.03.24
€23.40
Summary
This prediction ended on 05.03.24 with a price of €23.40. The price for EyePoint Pharmaceuticals Inc. massively increased, which is bad news for the SELL prediction by StockNews_com. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | -2.727% | -2.727% | 23.357% | 15.054% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % | 52,00 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % | 77,54 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % | 64,68 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % | 63,01 % |
Comments by StockNews_com for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.17
21.09.24
21.09.24
-
21.09.25
21.09.25
39.63%
22.09.25
22.09.25
